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Despite all progress in vaccine research against toxoplasmosis, subunit vaccines still deal 
with poor immunogenicity, which could be overcome by using efficient delivery vehicles 
like PLGA. The proteinaceous nature of antigens makes the loading of protein more 
challenging than chemical medicines. Here, we prepared rSAG1-PLGA by adsorption and 
encapsulation methods and compared their characterizations. 
Methods and Results:  
Blank PLGA and rSAG1-encapsulated PLGA nanospheres were prepared using double 
emulsion solvent evaporation technique at room temperature. rSAG1-adsorbed PLGA 
nanospheres were prepared by incubating a suspension of freeze-dried blank PLGA with 
rSAG1 in PBS (pH 7.4) and it was mixed at 4°C overnight. Size, PDI, zeta potential, 
preparation yield, and adsorption/encapsulation efficiency of all prepared PLGA nanospheres 













Blank PLGA  438 ± 11 0.12 ± 0.01 -5.56 ± 0.68 - 86.8 ± 3.56 
rSAG1-adsorbed  PLGA  486 ± 9.9 0.14 ± 0.02 -1.00 ± 0.33 69.73 ± 3.05 87.4 ± 2.7 
rSAG1-encapsulated 
PLGA  
471 ± 8.5 0.20 ± 0.04 -4.66 ± 0.6 46.93 ± 2.51 86.8 ± 2.86 
*Poly Dispersity Index, A; adsorption, E; encapsulation 
Moreover, in vitro release profile of both PLGA nanospheres during 4 
weeks demonstrated more or less similar release pattern (zero-order 
release patterns). However, rSAG1 release in rSAG1-encapsulated 
PLGA happened slower than release in rSAG1-adsorbed one. 
Conclusions: 
 Based on obtained size, both rSAG1-adsorbed and rSAG1-encapsulated particles could be 
efficiently taken up by presenting cells. Higher efficiency of adsorption than encapsulation 
makes adsorption method more economic in large scale. Protein during encapsulation 
process faces some stability problems due to exposure to harsh mechanical thermal and 
chemical stresses affecting protein integrity and immunogenicity. Therefore, protein 
adsorption would be applied as a suitable method for protein loading. We are going to 
evaluate the efficiency of both particles in eliciting immune responses in BALB/c. 
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